Welcome to the Pharmacy Homepage
The Colorado State Board of Pharmacy regulates pharmacists, pharmacy interns, pharmacy technicians, in-state and nonresident pharmacies, in-state and out-of-state prescription drug wholesalers, satellite pharmacies, specialized prescription drug outlets, other outlets, and limited licenses. The Board upholds consumer protection by licensing qualified applicants, investigating complaints, and enforcing disciplinary actions against violators of the Pharmacists, Pharmacy Business and Pharmaceuticals Act and the Board's rules.
The Board consists of five pharmacist members and two public members and works in conjunction with the Federal Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Colorado Pharmacists Society, RxPlus Pharmacies, and the Colorado Retail Council.
Program Information
- Program/Board Members
-
Dmitry Kunin, Senior Program Director
State Board of Pharmacy
1560 Broadway, Suite 1350
Denver, CO 80202Phone: 303-894-7800 | Fax: 303-894-7692 | Email: dora_pharmacyboard@state.co.us
Board Members:
-
Avani Soni, Pharm.D., RPh, President
Term Expires: July 1, 2025 -
Eric Frazer, Pharm.D., Vice President
Term Expires: July 1, 2025 -
Kristen Wolf, PharmD, BCSCP
Term Expires: July 1, 2027 -
Patricia A.Evacko, PharmD.
Term Expires: July 1, 2026 -
Ryan Leyland, PharmD, RPh
Term Expires: July 1, 2027 -
Alexandra Zuccarelli, MBA
Term Expires: July 1, 2027 -
Jayant Patel
Term Expires: July 1, 2027
-
- Public Notices
-
Permanent Rulemaking Hearing - October 5, 2023
The purpose of the Permanent Rulemaking Hearing is to receive testimony before the Board determines whether to repeal Rules 32.00.00 - PROTECTIONS FOR PROVISION OF REPRODUCTIVE HEALTH CARE IN COLORADO and 33.00.00 - PROTECTING COLORADO’S WORKFORCE AND EXPANDING LICENSING OPPORTUNITIES on a permanent basis to implement Colorado Senate Bill 23-188 (Concerning Protections for Accessing Reproductive Health Care) and Colorado Senate Bill 23-265 (Concerning a Prohibition on a Regulator Imposing Discipline Against a Person Based on Certain Activities Involving Marijuana). And to consider proposed changes to: Rule 5.01.40 – OUTLETS, Rule 11.06.10 – RECORDS AND RECORKEEPING, Rule 19.01.10 – ADMINISTRATION, Rules 1, 5, 11, 14, 21, 26, 27, 29, and 30 – PROFESSIONAL CONDUCT, OUTLETS, RECORDS AND RECORDKEEPING, OTHER OUTLETS, COMPOUNDING, REMOTE PHARMACY PRACTICE, HOSPITAL PHARMACY SATELLITE, PHARMACY TECHNICIANS, COVID-19 HEALTH RESPONSE RULE, Rule 23.00.70 – ELECTRONIC PRESCRIPTION MONITORING PROGRAM, Rule 3, 11, 17, 20, and 21 – DISPENSING, RECORDS AND RECORDKEEPING, COLLABORATIVE PHARMACY PRACTICE, CENTRAL PRESCRIPTION PROCESSING, and COMPOUNDING, Rule 5 – OUTLETS, Rule 2 – ORDERS, Rule 3 – DISPENSING, Rule 5 – OUTLETS, Rule 12 - NUCLEAR PHARMACY, and Rule 21 – COMPOUNDING.
- Thursday, October 5, 2023, at 9:00 A.M. (MDT)
- Permanent Rulemaking Hearing Notice
- Draft Rules
- Webinar Registration
- Written comments (Link will be updated as comments are received.)
- Stakeholder Meeting Recording - August 21, 2023 10:00 A.M.
- Stakeholder Meeting Recording - August 21, 2023 1:00 P.M
Emergency and Permanent Rulemaking Hearing - September 21, 2023
The Board of Pharmacy held a Rulemaking Hearing to allow stakeholders a final opportunity to testify before the Board determined whether to adopt the proposed new Rule 33.00.00 (RULES AND REGULATIONS REGARDING GENERALLY ACCEPTED STANDARDS OF PHARMACY PRACTICE REGARDING PREGNANCY-RELATED SERVICES) to implement Colorado Senate Bill 23-190(opens in new window) (Concerning Policies to Make Punishable Deceptive Actions regarding Pregnancy-Related Services.
- Adopted Rule 33.00.00 - Effective October 1, 2023
- Written Comments(opens in new window) (Link will be updated as comments are received.)
- Stakeholder Meeting Recordings:
- June 5, 2023
- August 4, 2023
Stakeholder Meetings - August 21, 2023
The State Board of Pharmacy ("Board") held multiple stakeholder meetings on August 21, 2023, to receive stakeholder feedback regarding multiple changes to the Board's rules and regulations in advance of the Board's Permanent Rulemaking Hearing on October 6, 2023. Please continue to submit written comments to dora_dpo_rulemaking@state.co.us.
- Stakeholder Meeting Notice - 10 a.m. Meeting
- Stakeholder Meeting Notice - 1 p.m. Meeting
- Draft Rules
- Written Comments (Link will be updated as comments are received.)
Joint Stakeholder Meeting - August, 4 2023
The Colorado Medical Board, Board of Nursing, and Board of Pharmacy will hold a virtual Stakeholder Meeting on August 4, 2023, for stakeholders to provide feedback regarding the proposed changes to implement Colorado Senate Bill 23-190 (Concerning Policies to Make Punishable Deceptive Actions Regarding Pregnancy-Related Services).
- Stakeholder Meeting: Friday, August 4, 2023, at 1:30 P.M.
- Meeting Notice
- Webinar Registration
- Written Comments (Link will be updated weekly as comments are received.)
Permanent and Emergency Rulemaking Hearing - July 20, 2023
The Colorado Board of Pharmacy will hold a Permanent and Emergency Rulemaking Hearing to allow stakeholders a final opportunity to provide testimony before the Board considers adopting the proposed revisions to Rule 5.00.00 on a permanent and emergency basis to implement Colorado House Bill 23-1195 (CONCERNING THE OPERATION OF AUTOMATED PHARMACY DISPENSING SYSTEMS).
- Thursday, July 20, 2023, at 9:00 A .M. (MDT)
- Hearing Notice
- Draft Rules
- Webinar Registration
- Sign up to Testify
- Written Stakeholder Comments (Link will be updated as comments are received.)
Joint Stakeholder Meeting - SB23-190 - June 5, 2023
The Colorado Medical Board, Board of Nursing, and Board of Pharmacy held a virtual Stakeholder Meeting on June 5, 2023, for stakeholders to provide feedback regarding what rules and regulations, if any, are necessary to implement Colorado Senate Bill 23-190 (Concerning Policies to Make Punishable Deceptive Actions Regarding Pregnancy-Related Services).
- Stakeholder Meeting: Monday, June 5, 2023, at 2:00 P.M.
- Meeting Notice
- Written Comments (Link will be updated weekly as comments are received.)
- Meeting Recording - June 5, 2023
REQUESTING WRITTEN STAKEHOLDER COMMENTS
Colorado Board of PharmacyWhat is this about?
The Colorado Board of Pharmacy ("Board") is requesting written comments regarding proposed rule revisions to Rule 5.00.00 - Outlets in order to implement Colorado House Bill 23-1195 (Concerning the Operation of Automated Pharmacy Dispensing Systems), which was signed into law by Governor Jared Polis on May 1, 2023. The Board will hold a Permanent and Emergency Rulemaking Hearing at its next meeting on July 20, 2023, to determine whether to adopt the proposed revisions to Rule 5.00.00 on a permanent and emergency basis. Please submit written comments to dora_dpo_rulemaking@state.co.us by June 9, 2023, the Board will continue to accept written comments until the Rulemaking Hearing on July 20, 2023. Written comments will be posted on the Board's website under the "Public Notices" tab as received for all stakeholders to review.
Joint Stakeholder Meeting - Opioid Guidelines - July 17, 2023
The Colorado State Board of Pharmacy, Colorado Dental Board, Colorado Medical Board, Colorado State Board of Nursing, Colorado State Board of Optometry, Colorado Podiatry Board, and Colorado State Board of Veterinary Medicine are holding a virtual Stakeholder Meeting on July 17, 2023, for stakeholders to provide feedback regarding Colorado’s Guidelines for the Safe Prescribing and Dispensing of Opioids as these guidelines relate to the United States Centers for Disease Control and Prevention’s (CDC) updated Clinical Practice Guideline for Prescribing Opioids for Pain.
- Stakeholder Meeting notice: Monday, July 17, 2023, at 12:30 p.m.
- Stakeholder Written Comments (Link will be updated weekly as comments are received.)
- Stakeholder Meeting Recording
- Legislative Updates
-
- 2023 New Legislation
- HB 23-1002: Epinephrine Auto Injectors
- HB23-1071: Licensed Psychologist Psychotropic Medication Prescribing
- HB 23-1195: Automated Pharmacy Dispensing System
- SB23-102: Rule Review Bill
- SB 23-144: Prescription Drugs for Chronic Pain
- SB 23-162: Increase Access to Pharmacy Services
- SB 23-176: Protections for People with Eating Disorders
- SB23-265: SB 23-265: Prohibit Professional Discipline for Marijuana
- SB 23-286: Access to Government Records
- 2022 New Legislation
- HB22-1041: Privacy Protections For Protected Persons
- HB22-1098: Department Of Regulatory Agencies Barriers To Practice Regulated Professions
- HB22-1115: Prescription Drug Monitoring Program
- HB22-1165: Rule Review Bill
- HB22-1240: Mandatory Reporters
- HB22-1246: Hospice Inpatient Unit Specialized Prescription Drug Outlet
- HB22-1257: 2022 Criminal And Juvenile Justice Commission Recommendations
- HB22-1267 Culturally Relevant Training Health Professionals
- HB22-1270: Change Term Name-based Criminal History Record Check
- HB22-1278: Behavioral Health Administration
- HB22-1309: Hospital Dispense Drugs To Sexual Assault Victims
- HB22-1326: Fentanyl Accountability And Prevention
- HB22-1291: Sunrise Review Professions Occupations
- SB22-013: Boards and Commissions
- SB22-027: Prescription Drug Monitoring Program
- SB22-076: Complaint Occupational License Official Acts
- SB22-098 Program Allowing Redispensing Of Unused Drugs
- SB22-116 Increase Occupational Credential Portability
- SB22-140 Expansion Of Experiential Learning Opportunities
- SB22-143 Update Common Provision Term Regulator Title 12
- SB22-162: Administration Organization Act Modernization
- SB22-173: Telepharmacy Criteria Remove Location Restriction
- SB22-174: Sunset Review Hearing Criteria
- SB22-226: Programs To Support Health-care Workforce
- 2021 New Legislation
- HB21-1012 Expand Prescription Drug Monitoring Program
- HB21-1198: Healthcare Billing Requirements for Indigent Patients
- HB 21-1123: CAPS Check for Substantiated Cases of Mistreatment of an At-Risk Adult
- HB21-1169: Prohibit Discrimination Organ Transplant Recipient
- HB21-1232: Standardized Health Benefit Plan Colorado Option
- HB21-1276 Prevention of Substance Use Disorders
- HB21-1297: Pharmacy Benefit Manager and Insurer Requirements
- HB21-1300: Health-care Provider Liens for Injured Persons
- HB21-1307: Prescription Insulin Pricing And Access
- SB21-011: Pharmacist Prescribe Dispense Opiate Antagonist
- SB21-077: Remove Lawful Presence Verification Credentialing
- SB21-094: Sunset Continue State Board of Pharmacy
- SB21-097: Sunset Medical Transparency Act
- SB21-098: Sunset Prescription Drug Monitoring Program
- SB21-122: Opiate Antagonist Bulk Purchase And Standing Orders
- SB21-123: Expand Canadian Rx Import Program
- SB21-271: Misdemeanor Reform
- 2023 New Legislation
- Meeting Minutes
-
Board Meeting Minutes
- June 8, 2023, Pharmacy Board Meeting Minutes
- May 18, 2023, Pharmacy Board Meeting Minutes
- March 16, 2023, Pharmacy Board Meeting Minutes
Veterinary Pharmaceutical Advisory Committee (VPAC) Minutes